Generex Biotechnology Corp. (Worcester, MA) has formed an agreement with a nationwide pharmacy chain to market its Crave-NX 7-Day Diet Aid Spray in all of the chain’s stores. Sprayed into the mouth, the orange-flavored product is formulated to quickly curb cravings throughout the day.
Generex said it has received an aggregate of over $800,000 initial purchase orders for the chain’s 7,000 stores, and will support the product launch with TV, radio, and print ads. http://www.barkerdzp.com/cravenx/
Engaged in research, development, and commercialization of drug delivery systems, Generex has developed a platform technology for delivery of drugs via the oral cavity. The firm’s proprietary liquid formulations are administered for absorption into the body by the lining of the inner mouth using the firm’s RapidMist device. Its flagship product, Oral-lyn oral insulin, is available for sale in India, Lebanon, Algeria, and Ecuador, for treatment of Type-1 and 2 diabetes.